Abstract

You have accessJournal of UrologyCME1 May 2022MP29-10 AQUABLATION IN VERY LARGE PROSTATES (>150ML): TECHNIQUE AND MULTICENTER CASE SERIES Alexander Glaser, Brian Helfand, Ali Kasraeian, Steve Sterious, Pooja Talaty, Miguel Alcantara, Kaitlyn Alcantara, Andrew Higgins, Eric Ghiraldi, and Dean Elterman Alexander GlaserAlexander Glaser More articles by this author , Brian HelfandBrian Helfand More articles by this author , Ali KasraeianAli Kasraeian More articles by this author , Steve SteriousSteve Sterious More articles by this author , Pooja TalatyPooja Talaty More articles by this author , Miguel AlcantaraMiguel Alcantara More articles by this author , Kaitlyn AlcantaraKaitlyn Alcantara More articles by this author , Andrew HigginsAndrew Higgins More articles by this author , Eric GhiraldiEric Ghiraldi More articles by this author , and Dean EltermanDean Elterman More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002572.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Aquablation has been well-studied in men with prostate volume (PV) <150ml. AUA guidelines distinguish surgical interventions for men with large prostates (80-150ml) and very large prostates (>150ml). In this study, we describe the technique for Aquablation in men with PV>150mL and outcomes in a multicenter case series. METHODS: Additional procedural steps for men with PV>150mL are often needed based on the maximum ablation length (7cm) and depth (2.4cm) (Figure 1). After the first pass, the handpiece position should be adjusted by tipping the handpiece down to maximize depth (Figure 2). For long prostates (>7cm), the handpiece should then be leveled and re-positioned at the external sphincter, then a third pass completed (Figure 3). Focal bladder neck hemostasis is then performed as previously described. Data from was collected retrospectively for men with PV>150mL including international prostate symptom score (IPSS), peak urinary flow rate (Qmax), length of stay, and blood transfusion. RESULTS: Thirty-four men (age 69 ± 8) were treated at four institutions. The average PV was 209mL ± 56 (range 151-362mL). Symptoms improved from a baseline IPSS 19 ± 6 to 7 ± 5 after mean follow-up of 7 ± 9 months. Qmax also improved from 7 ± 4 mL/s to 19 ± 5 mL/s. There were no reports of transfusion, urinary incontinence, erectile dysfunction, or ejaculatory dysfunction, and most patients were discharged POD1. CONCLUSIONS: Most prostates greater than 150mL typically require repositioning of the handpiece for either depth or length. Preliminary data suggests Aquablation is effective and safe in prostates greater than 150mL. Source of Funding: Drs. Helfand, Kasraeian, Sterious, and Elterman have had or currently have a consulting agreement with PROCEPT BioRobotics. No funding was received this manuscript © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e472 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alexander Glaser More articles by this author Brian Helfand More articles by this author Ali Kasraeian More articles by this author Steve Sterious More articles by this author Pooja Talaty More articles by this author Miguel Alcantara More articles by this author Kaitlyn Alcantara More articles by this author Andrew Higgins More articles by this author Eric Ghiraldi More articles by this author Dean Elterman More articles by this author Expand All Advertisement PDF DownloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call